At FormBlends, we see women using GHK-Cu for a range of goals, from reducing fine lines to supporting post-surgical recovery
Furthermore, therapeutic application of BV includes their use in the management of bursitis, tendonitis, dissolving scar tissue, in the management of post herpetic neuralgia, Lyme disease, rheumatoid arthritis, osteoarthritis, multiple sclerosis, TMDs, and more (Table 5) (Kurek-Grecka et al., 2020)
These proteins are: horse heart apocytochrome c (Stellwagen et al., 1972), protein phosphatase inhibitor-1 from rabbit skeletal muscle (19.2 kDa by sedimentation and 60.0 kDa by gel-filtration) (Nimmo and Cohen, 1978), a dopamine-and adenosine 3:5-monophosphate-regulated phosphoprotein from bovine caudate nucleus, DARPP-32 (27.6 kDa by sedimentation and 59 kDa by gel-filtration) (Hemmings et al., 1984), bovine cardiac troponin C in the absence of calcium (McCubbin and Kay, 1985), heat-stable microtubule-associated protein MAP2 (Hernandez et al., 1986), smooth muscle caldesmon (Lynch et al., 1987), brain-specific 14-kDa protein (14 kDa by Sodium Dodecyl Sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and 57 kDa by gel filtration) (Nakajo et al., 1990), carboxyl-terminal transactivation domain of Vmw65 from herpes simplex virus type 1 (11.0 kDa from sedimentation and 55.0 kDa from gel-filtration) (Donaldson and Capone, 1992), prothymosin (Stokes radius is 1.77 larger than those expected for a compactly folded protein consisting of 109 amino acid residues) (Gast et al., 1995), chromogranin B (100 kDa by SDS-PAGE and 220 kDa by gel-filtration) (Yoo, 1995), human topoisomerase I (66 kDa by sedimentation and 300 kDa by gel-filtration) (Stewart et al., 1996), N-terminal domain of human topoisomerase I (198 residues, 66 kDa by sedimentation and 96 kDa by gel filtration) (Stewart et al., 1996), oncoprotein 18 (Op18)/stathmin from fetal calf thymus (17.22 kDa by mass-spectrometry and 64 kDa by gel-filtration) (Schubart et al., 1987
The Diabetes Prevention Program (DPP): description of lifestyle intervention
A long non-coding RNA targets microRNA miR-34a to regulate colon cancer stem cell asymmetric division
